NewsDesk @bactiman63 Bavarian Nordic A/S announced Thursday that the Company has secured a contract with an undisclosed European country to supply its IMVANEX® smallpox vaccine in response to new cases...

NewsDesk @bactiman63 Smallpox is one of the most devastating diseases in the history of mankind. Believed to originate more than three millennia in India or Egypt, epidemics caused by smallpox have decimated...

By NewsDesk  @bactiman63 In a follow-up on reports of several vials labeled “smallpox” found at a Pennsylvania vaccine facility, the Centers for Disease Control and Prevention (CDC) reports...

By NewsDesk  @infectiousdiseasenews The U.S. Food and Drug Administration Friday approved Tembexa (brincidofovir) to treat smallpox. Although the World Health Organization declared smallpox, a contagious...

By Robert Herriman  @bactiman63 US and global health security-what is it, what was the genesis and how prepared are we? These are some of the things I look at in this interview with experts in the field. In...

Bavarian Nordic A/S announced today that Health Canada has expanded the approval of the Company’s non-replicating smallpox vaccine, IMVAMUNE® to include additional indications – specifically, monkeypox...

Bavarian Nordic A/S  announced  topline results from the pivotal Phase 3 study of the freeze-dried formulation of its MVA-BN® smallpox vaccine. The Phase 3 lot-consistency study was agreed with the...

By NewsDesk  @infectiousdiseasenews In this video, I take a look at the rare, viral infection in humans, and cows for that matter, cowpox. I look at the infection in cattle, in humans and in cats–the...

During a press briefing at United Nations Information Service in Geneva, the following was commemorated: Dr. Rosamund Lewis, Head of the Smallpox Secretariat at the World Health Organization (WHO), said...

In his first hand account of the United States Army Medical Research Institute of Infectious Diseases (USAMRIID), physician and retired Army Colonel, Mark Kortepeter, MD pens the edge of you seat book,...